112 related articles for article (PubMed ID: 1806036)
1. Nitroxyl radicals decrease toxicity of cytostatic agents.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Varfolomeev VN
Anticancer Drugs; 1991 Dec; 2(6):591-5. PubMed ID: 1806036
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of tempol on toxicity and antitumor activity of 6-mercaptopurine and on P450 cytochrome level.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Varfolomeev VN
Neoplasma; 1996; 43(5):341-6. PubMed ID: 8996555
[TBL] [Abstract][Full Text] [Related]
3. [In vitro cytotoxicity of nitroxyl radicals with respect to tumor and diploid human cells and estimation of their antiviral activity].
Kiriliuk IA; sviatchenko VA; Morozov DA; Kazachinskaia EI; Kiselev NN; Bakunova SM; Voĭnov MA; Loktev VB; Grigor'ev IA
Antibiot Khimioter; 2012; 57(1-2):3-12. PubMed ID: 22741195
[TBL] [Abstract][Full Text] [Related]
4. Effects of antitumor agents and hyperbaric oxygen in normal and tumor-bearing rodents.
Nathanson L; Brown B; Maddock C; Hall TC
Cancer; 1966 Jul; 19(7):1019-25. PubMed ID: 4161090
[No Abstract] [Full Text] [Related]
5. [Animal experimental studies on the immunosuppressive effect of cytostatic agents].
Scherf HR; Karsten C; Krüger C
Langenbecks Arch Chir; 1969; 325():1028-33. PubMed ID: 4984531
[No Abstract] [Full Text] [Related]
6. [The effect of nitroxyl radicals and sodium nitrite on the methemoglobin content of the blood and on the enzymatic activity of erythrocyte antioxidant protection].
Shugaleĭ IV; Tselinskiĭ IV; Kashparova VP; Kashparov IS
Ukr Biokhim Zh (1978); 1992; 64(6):87-90. PubMed ID: 1488819
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome c/H2O2-mediated one electron oxidation of carcinogenic N-fluorenylacetohydroxamic acids to nitroxyl free radicals.
Ritter CL; Malejka-Giganti D; Polnaszek CF
Chem Biol Interact; 1983 Sep; 46(3):317-34. PubMed ID: 6315247
[TBL] [Abstract][Full Text] [Related]
8. [Nitroxyl radical Tempol as a modulator of toxic and antineoplastic effect of 6-mercaptopurine].
Konovalova NP; D'iachkovskaia RF; Volkova LM; Varfolomeev VN
Vopr Onkol; 1996; 42(3):57-63. PubMed ID: 8801743
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant action of a lipophilic nitroxyl radical, cyclohexane-1-spiro-2'-(4'-oxyimidazolidine-1'-oxyl) -5'-spiro-1"-cyclohexane, against lipid peroxidation under hypoxic conditions.
Shimakawa S; Yoshida Y; Niki E
Lipids; 2003 Mar; 38(3):225-31. PubMed ID: 12784862
[TBL] [Abstract][Full Text] [Related]
10. Conjugates of natural compounds with nitroxyl radicals as a basis for creation of pharmacological agents of new generation.
Grigor'ev IA; Tkacheva NI; Morozov SV
Curr Med Chem; 2014; 21(24):2839-52. PubMed ID: 24606494
[TBL] [Abstract][Full Text] [Related]
11. Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.
Xu Y; Hansen WK; Rosenquist TA; Williams DA; Limp-Foster M; Kelley MR
J Pharmacol Exp Ther; 2001 Mar; 296(3):825-31. PubMed ID: 11181913
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of novel nitroxyl radicals with reduction stability.
Kinoshita Y; Yamada K; Yamasaki T; Mito F; Yamato M; Kosem N; Deguchi H; Shirahama C; Ito Y; Kitagawa K; Okukado N; Sakai K; Utsumi H
Free Radic Biol Med; 2010 Dec; 49(11):1703-9. PubMed ID: 20828609
[TBL] [Abstract][Full Text] [Related]
13. [Antileukemic activity and development of resistance to cisplatin (CPT) and platinum (IV)-nitroxyl complex VS118].
Goncharova SA; Raevskaia TA; Iakushchenko TN; Blokhina SV; Konovalova NP; Sen' VD
Vopr Onkol; 2011; 57(3):355-8. PubMed ID: 21882607
[TBL] [Abstract][Full Text] [Related]
14. Nitroxyl analogs as inhibitors of aldehyde dehydrogenase. C-nitroso compounds.
Nagasawa HT; Yost Y; Elberling JA; Shirota FN; DeMaster EG
Biochem Pharmacol; 1993 May; 45(10):2129-34. PubMed ID: 8512594
[TBL] [Abstract][Full Text] [Related]
15. Modulation of alkylating agents by lonidamine in vivo.
Teicher BA; Holden SA; Herman TS; Frei E
Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
[TBL] [Abstract][Full Text] [Related]
16. Influence of scheduling on two-drug combinations of alkylating agents in vivo.
Teicher BA; Holden SA; Jones SM; Eder JP; Herman TS
Cancer Chemother Pharmacol; 1989; 25(3):161-6. PubMed ID: 2513139
[TBL] [Abstract][Full Text] [Related]
17. Hematologic and cytogenetic effects of androgens in cytostatic-treated mice (the micronucleus test).
Ioan D
Endocrinologie; 1981; 19(3):179-81. PubMed ID: 6794141
[No Abstract] [Full Text] [Related]
18. Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.
Rae JM; Soukhova NV; Flockhart DA; Desta Z
Drug Metab Dispos; 2002 May; 30(5):525-30. PubMed ID: 11950782
[TBL] [Abstract][Full Text] [Related]
19. Development of novel nitroxyl radicals for controlling reactivity with ascorbic acid.
Kinoshita Y; Yamada K; Yamasaki T; Sadasue H; Sakai K; Utsumi H
Free Radic Res; 2009 Jun; 43(6):565-71. PubMed ID: 19384748
[TBL] [Abstract][Full Text] [Related]
20. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
